Sandra A. Frantzen to Speak on PTAB Proceedings at CBI’s Patent Strategy & Portfolio Planning for Life Sciences Congress
McAndrews, Held & Malloy Shareholder Sandra A. Frantzen will present at CBI’s Patent Strategy & Portfolio Planning for Life Sciences Congress on December 8-9, 2015. CBI is a leader in conferences for the pharmaceutical industry.
The event is designed exclusively for IP and patent counsel at brand and generic pharma and biotech companies, and private practice life sciences patent lawyers. Frantzen will present “PTAB Proceedings—Strategic Considerations in Pre-Trial Practices.”
At McAndrews, Frantzen focuses her practice on litigation for the medical device and pharmaceutical industries. Along with litigating patent cases in federal court, she is well-versed in handling proceedings with the Patent Office and is currently lead trial counsel in several inter partes review proceedings.
The Patent Strategy & Portfolio Planning for Life Sciences Congress will provide pharma and biotech attorneys with insights into preparing for the ever-changing patent legal landscape. It will focus on the impact of PTO post-grant proceedings on patents strategy, and how to deliver actionable IPR and biosimilar legal strategies for the next proceeding. Attendees are eligible to receive 9.5 CLE credits.
For more information and to register, click here.
Sandra A. Frantzen, Esq., is a trial attorney and litigator who practices a broad range of intellectual property law focusing on patent, trademark and copyright litigation, and client counseling in various industries, with a particular focus in the medical device and pharmaceutical industries. Her work includes formulating litigation and dispute resolution strategy, appearing and arguing in court as lead trial counsel, participating in and preparing for jury trials and arbitration proceedings, and working with witnesses and experts. Frantzen also regularly advises clients on strategic IP development, acquisition, protection and enforcement with a focus on value. In 2014, she was featured as one of the “40 Illinois Attorneys Under 40 to Watch.”